Psn Medicare Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 9.60 M
- Revenue Growth 2.47%
- Profit Growth -17.55%
- Ebitda -20.76%
- Net Worth 33.40%
- Total Assets 36.73%
About Psn Medicare
Psn Medicare Private Limited (PMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 February 2014 and has a history of Ten years and 11 months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹9.60 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ramadevi Nemallapudi and Kasthur Nemallapudi serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24100TG2014PTC092665
- Company No.
092665
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Feb 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Psn Medicare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramadevi Nemallapudi  | Director | 03-Feb-2014 | Current |
| Kasthur Nemallapudi | Director | 03-Feb-2014 | Current |
Financial Performance of Psn Medicare.
Psn Medicare Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.47% increase. The company also saw a substantial fall in profitability, with a 17.55% decrease in profit. The company's net worth Soared by an impressive increase of 33.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Psn Medicare?
In 2023, Psn Medicare had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Leesa Lifesciences Private LimitedRamadevi Nemallapudi and Kasthur Nemallapudi are mutual person
Charges (Loans)
₹0
₹0.96 Cr
Charges Breakdown by Lending Institutions
- Syndicate Bank : 0.96 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Sep 2018 | Syndicate Bank | ₹2.10 M | Satisfied |
| 17 Apr 2014 | Syndicate Bank | ₹7.50 M | Satisfied |
How Many Employees Work at Psn Medicare?
Unlock and access historical data on people associated with Psn Medicare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Psn Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Psn Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.